140
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Cardiovascular and Other Competing Causes of Death in Male Breast Cancer Patients: A Population-Based Epidemiologic Study

ORCID Icon, , , , , , , , ORCID Icon & show all
Pages 1393-1401 | Published online: 20 Jul 2021

References

  • Giordano SH, Longo DL. Breast cancer in men. N Engl J Med. 2018;378(24):2311–2320. doi:10.1056/NEJMra170793929897847
  • Abdelwahab Yousef AJ. Male breast cancer: epidemiology and risk factors. Semin Oncol. 2017;44(4):267–272. doi:10.1053/j.seminoncol.2017.11.00229526255
  • Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.2165433433946
  • Konduri S, Singh M, Bobustuc G, Rovin R, Kassam A. Epidemiology of male breast cancer. Breast. 2020;54:8–14. doi:10.1016/j.breast.2020.08.01032866903
  • Speirs V, Shaaban AM. The rising incidence of male breast cancer. Breast Cancer Res Treat. 2009;115(2):429–430. doi:10.1007/s10549-008-0053-y18478326
  • Reddington R, Galer M, Hagedorn A, et al. Incidence of male breast cancer in Scotland over a twenty-five-year period (1992–2017). Eur J Surg Oncol. 2020;46(8):1546–1550. doi:10.1016/j.ejso.2020.01.00931955992
  • Hassett MJ, Somerfield MR, Baker ER, et al. Management of male breast cancer: ASCO guideline. J Clin Oncol. 2020;38:1849–1863.32058842
  • Piscuoglio S, Ng CK, Murray MP, et al. The genomic landscape of male breast cancers. Clin Cancer Res. 2016;22(16):4045–4056. doi:10.1158/1078-0432.CCR-15-284026960396
  • Masci G, Caruso M, Caruso F, et al. Clinicopathological and immunohistochemical characteristics in male breast cancer: a retrospective case series. Oncologist. 2015;20(6):586–592. doi:10.1634/theoncologist.2014-024325948676
  • Gucalp A, Traina TA, Eisner JR, et al. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat. 2019;173(1):37–48. doi:10.1007/s10549-018-4921-930267249
  • Fentiman IS. Male breast cancer is not congruent with the female disease. Crit Rev Oncol Hematol. 2016;101:119–124. doi:10.1016/j.critrevonc.2016.02.01726989051
  • Zaorsky NG, Churilla TM, Egleston BL, et al. Causes of death among cancer patients. Ann Oncol. 2017;28(2):400–407. doi:10.1093/annonc/mdw60427831506
  • Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a Retrospective Cohort Study. Breast Cancer Res. 2011;13(3):R64. doi:10.1186/bcr290121689398
  • Bardia A, Arieas ET, Zhang Z, et al. Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer. Breast Cancer Res Treat. 2012;131(3):907–914. doi:10.1007/s10549-011-1843-122042368
  • Runowicz CD, Leach CR, Henry NL, et al. American cancer society/American society of clinical oncology breast cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611–635. doi:10.1200/JCO.2015.64.380926644543
  • Mehta LS, Watson KE, Barac A, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American heart association. Circulation. 2018;137(8):e30–e66. doi:10.1161/CIR.000000000000055629437116
  • Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 1998;83(3):498–509. doi:10.1002/(SICI)1097-0142(19980801)83:3<498::AID-CNCR19>3.0.CO;2-R9690543
  • Kwong A, Chau WW, Mang OW, et al. Male breast cancer: a population-based comparison with female breast cancer in Hong Kong, Southern China: 1997–2006. Ann Surg Oncol. 2014;21(4):1246–1253. doi:10.1245/s10434-013-3377-824337541
  • Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28(2):232–239. doi:10.1200/JCO.2009.23.816219996029
  • National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER data & software. Available from: https://seer.cancer.gov/data-software/. Accessed 219, 2021.
  • Centers for Disease Control and Prevention. About multiple cause of death, 1999–2019. Available from: https://wonder.cdc.gov/mcd-icd10.html. Accessed 219, 2021.
  • National Cancer Institute Surveillance, Epidemiology, and End Results Program. SEER cause of death recode 1969+ (03/01/2018) SEER data reporting tools. Available from: https://seer.cancer.gov/codrecode/1969_d03012018/index.html. Accessed 219, 2021.
  • Ye Y, Otahal P, Marwick TH, Wills KE, Neil AL, Venn AJ. Cardiovascular and other competing causes of death among patients with cancer from 2006 to 2015: an Australian Population-Based Study. Cancer. 2019;125(3):442–452. doi:10.1002/cncr.3180630311655
  • Altman DG, Bland JM. How to obtain the P value from a confidence interval. BMJ. 2011;343(aug08 1):d2304. doi:10.1136/bmj.d230422803193
  • Breslow NE, Day NE. Statistical methods in cancer research. Volume II – the design and analysis of cohort studies. IARC Sci Publ. 1987;82:1–406.
  • Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244–256. doi:10.1093/aje/kwp10719494242
  • Gnerlich JL, Deshpande AD, Jeffe DB, Seelam S, Kimbuende E, Margenthaler JA. Poorer survival outcomes for male breast cancer compared with female breast cancer may be attributable to in-stage migration. Ann Surg Oncol. 2011;18:1837–1844.21484520
  • Sturgeon KM, Deng L, Bluethmann SM, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40(48):3889–3897. doi:10.1093/eurheartj/ehz76631761945
  • Eggemann H, Brucker C, Schrauder M, et al. Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis. Br J Cancer. 2020;123(1):33–37. doi:10.1038/s41416-020-0857-z32367072
  • Eggemann H, Bernreiter AL, Reinisch M, et al. Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis. Br J Cancer. 2019;120(3):301–305. doi:10.1038/s41416-018-0369-230655614
  • Reiner AS, Navi BB, DeAngelis LM, Panageas KS. Increased risk of arterial thromboembolism in older men with breast cancer. Breast Cancer Res Treat. 2017;166(3):903–910. doi:10.1007/s10549-017-4433-z28836029
  • Myrehaug S, Pintilie M, Yun L, et al. A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease. Blood. 2010;116(13):2237–2240. doi:10.1182/blood-2010-01-26376420595518
  • Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367(9510):595–604. doi:10.1016/S0140-6736(06)68226-316488803
  • Crew KD, Neugut AI, Wang X, et al. Racial disparities in treatment and survival of male breast cancer. J Clin Oncol. 2007;25(9):1089–1098. doi:10.1200/JCO.2006.09.171017369572